| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8178 |
| Human Intestinal Absorption | HIA+ | 0.9857 |
| Caco-2 Permeability | Caco2+ | 0.5401 |
| P-glycoprotein Substrate | Non-substrate | 0.7596 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8803 |
| Non-inhibitor | 0.9818 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8979 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5657 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6949 |
| CYP450 2D6 Substrate | Non-substrate | 0.8866 |
| CYP450 3A4 Substrate | Non-substrate | 0.7066 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9405 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7612 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9611 |
| Non-inhibitor | 0.8328 |
| AMES Toxicity | Non AMES toxic | 0.7300 |
| Carcinogens | Non-carcinogens | 0.8187 |
| Fish Toxicity | Low FHMT | 0.6442 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6134 |
| Honey Bee Toxicity | Low HBT | 0.7989 |
| Biodegradation | Not ready biodegradable | 0.9960 |
| Acute Oral Toxicity | III | 0.8004 |
| Carcinogenicity (Three-class) | Non-required | 0.5426 |